Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anfarm Hellas is a leading Greek pharmaceutical manufacturer established in 1967, specializing in the development, production, licensing, and international sales of high-quality generic pharmaceuticals. The company has extensive expertise in sterile drug production, particularly in beta-lactams, lyophilized products, and liquid injectables. Operating from state-of-the-art EU GMP-compliant manufacturing facilities in Schimatari, Greece, Anfarm Hellas serves both domestic and international markets, with exports contributing to over 60% of its total turnover. In addition to its proprietary generic portfolio, the company is a highly reputable contract development and manufacturing organization (CDMO) partner for major international pharmaceutical companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anfarm Hellas.